The emergence of SARS-CoV-2, the virus responsible for COVID-19, swept across the globe with an unparalleled speed and severity. As a researcher dedicated to understanding how viral infections lead to chronic illness, I knew this pandemic would have far-reaching...
Promising Clinical Trial Results: Advancing ME/CFS and Long COVID Treatment by Suzanne Vernon, PhD, Director of Research At the Bateman Horne Center (BHC), we are committed to finding effective treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)...
This past summer, we completed an open-label, proof of concept trial using a combination of valacyclovir, the generic form of Valtrex, and celecoxib, the generic form of Celebrex to see if it improved symptoms in women sick with Long COVID. The combination of these...
I met Armin Alaedini in 2008 at a meeting in San Francisco that was about solutions for Lyme and other tick-borne diseases through cutting edge science. I was fascinated by his presentation on immunological findings in post-treatment Lyme disease and I approached him...
This week our paper about possible causes of brain fog in ME/CFS and Long COVID was published in Frontiers of Neuroscience. This study included a large group of ME/CFS patients, Long COVID patients, and matched healthy controls. We hypothesized that cognitive...
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world. Bateman served as a clinical expert on the 2015 IOM/NAM committee, contributing her expertise in the development of the clinical diagnostic criteria for ME/CFS, a pivotal and influential moment for all clinicians, researchers, and patients. Medical and scientific collaborations include work with Stanford, Columbia, Cornell, Harvard, CDC, NIH, RECOVER Initiative, Riken, and she is the co-founder of the U.S. ME/CFS Clinician Coalition. In 2015 she expanded her impact by combining her private clinical and research practice with its sister non-profit, OFFER, to create a medical center of excellence, BHC, dedicated to the diagnosis, management, research, and education for the benefit of individuals impacted by msCCD. Her passion for increasing access to informed medical care fuels her focus on medical education today.
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.
Bateman served as a clinical expert on the 2015 IOM/NAM committee, contributing her expertise in the development of the clinical diagnostic criteria for ME/CFS, a pivotal and influential moment for all clinicians, researchers, and patients. Medical and scientific collaborations include work with Stanford, Columbia, Cornell, Harvard, CDC, NIH, RECOVER Initiative, Riken, and she is the co-founder of the U.S. ME/CFS Clinician Coalition.
In 2015 she expanded her impact by combining her private clinical and research practice with its sister non-profit, OFFER, to create a medical center of excellence, BHC, dedicated to the diagnosis, management, research, and education for the benefit of individuals impacted by msCCD. Her passion for increasing access to informed medical care fuels her focus on medical education today. Read her full bio here.Â
Many employers use platforms such as United Way, Benevity, Bright Funds, and Community Health Charities (CHC) to support charitable giving. Ask your employer how they support charitable giving and how Bateman Horne Center of Excellence can be included. Bateman Horne Center of Excellence is a 501c3 non-profit organization. EIN #87-0687610
For more information or questions contact us at [email protected]
Please indicate the honoree's name and who (if anyone) we should notify of the gift. To give by check make it payable to Bateman Horne Center and mail to: 24 South 11 East Suite 205, Salt Lake City, Utah 84102 Click here to give online.
Bateman Horne Center Donate
Check-Instructions
Donate Monthly
Contact Angela Linford, Development Officer about how you can include Bateman Horne Center in your will or estate planning.
Gifts of long-term appreciated securities offer you an advantageous way to support Bateman Horne Center and minimize capital gains taxes.
For more information on making a large gift or donating stock please contact Rob Ence, Executive Director, at [email protected]
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.